Clear Search
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Oct. 26, 2020

In the news: COVID-19 cases in the U.S., USPSTF draft recommendation for colorectal cancer screening, requirement for insurers to disclose prices.

Publications & Newsletters
·
12 MIN READ

Oct. 9, 2020: National Advocacy Update

Register for AMA webinar next week: CDC update on COVID-19 vaccine development and distribution and more in the latest National Advocacy Update.

Advocacy Update
Person using their credit card at a laptop
·
2 MIN READ

What your patients must know about Rx shopping online

Millions of newly uninsured Americans may look online to save money on prescription drugs. Here are some important safety tips your patients should know.

Public Health
·
6 MIN READ

July 31, 2020: National Advocacy Update

Physicians to Congress: Now is not the time for divisive surprise billing legislation and more in the latest National Advocacy Update.

Advocacy Update
·
7 MIN READ

May 29, 2020: National Advocacy Update

Telehealth coverage for ERISA plans is needed and more in the latest National Advocacy Updates.

Advocacy Update
Tight shot of pharmacist reading text on prescription box
·
4 MIN READ

What states are doing to combat rising prescription drug prices

Learn about the approaches, such as price transparency, that are being tried at the state level to address prescription drug skyrocketing costs.

Public Health
Indiana doctors in Washington for the 2020 AMA National Advocacy Conference, meet with Rep. Trey Hollingsworth, R, Ind.
·
6 MIN READ

Doctors take message on surprise-billing fix to Capitol Hill

80% favor action on the issue. Learn how the AMA is fighting for patient protections from unanticipated medical bills and stronger provider network regulations to ensure fair payment to out-of-network physicians.

Access to Care
Delegate Niva Lubin-Johnson, MD, speaking at 2019 HOD Interim Meeting.
·
4 MIN READ

AMA develops Rx for drug prices that are high and rising

Arbitration can be used in determining price of prescription drugs that have insufficient competition, high list prices, or have seen unjustifiable price increases.

Public Health
·
3 MIN READ

AMA sharpens policy to promote reasonable drug prices

Physicians adopt principles for the use of drug price arbitration and international price indices.

Press Releases